Japanese stocks may remain rangebound as uncertainty over the Middle East conflict continues. Nikkei futures are flat at 68675 on the SGX. The dollar is at 161.31 yen, down from Y162.25 as of Thursday's Tokyo stock market close, following disappointing U.S. jobs data. Investors are focusing on any…
1948 ET - Japanese stocks may remain rangebound as uncertainty over the Middle East conflict continues. Nikkei futures are flat at 68675 on the SGX. The dollar is at 161.31 yen, down from Y162.25 as of Thursday's Tokyo stock market close, following disappointing U.S. jobs data. Investors are focusi…
Oil falls in early trade as concerns over supply disruptions in the Middle East continue to ease. "While the U.S.-Iran process remains fragile and disputes over [Strait of] Hormuz administration and transit fees persist, we expect the [memorandum of understanding] to hold and turn into a deal over…
Karoon Energy Price Target Raised 2.1% to A$1.48/Share by Macquarie
Downer EDI Price Target Raised 2.3% to A$8.90/Share by Macquarie
Objective Price Target Cut 51% to A$10.80/Share by Shaw & Partners
Golden Horse Minerals Price Target Cut 17% to A$1.25/Share by Shaw & Partners
Regal Partners Price Target Raised 2.1% to A$4.80/Share by Bell Potter
Echo IQ Downgraded to Speculative Hold from Buy by Bell Potter
Echo IQ Price Target Raised 6.1% to A$1.75/Share by Bell Potter
Life360 Price Target Raised 6.1% to A$35.00/Share by Bell Potter
Wealth manager AMP can pursue more capital management, UBS says. It assumes further returns of A$150 million in 2H26. AMP had A$287 million of surplus CET1 capital--essentially a buffer against financial shocks--and that will build as profit grows. UBS also points to AMP's seemingly low dividend po…
Intelligent Monitoring Group Price Target Raised 19% to A$1.25/Share by Canaccord Genuity
Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity
Celltrion 2Q Op Pft Estimate Beat FactSet-Compiled Market Consensus
Mayne Pharma Moved to Speculative Buy from Buy by Canaccord Genuity
Celltrion Sees 2Q Op Pft KRW430.00B, Up 77% on Year >068270.SE
Celltrion Sees 2Q Rev KRW1.300T, Up 35% on Year >068270.SE
Objective Price Target Cut 25% to A$16.00/Share by Morgan Stanley
Australian stock futures are pointing to an opening rise ahead of the week's final trading session. ASX futures are up by about 0.6% before Friday's open, suggesting that the S&P/ASX 200 could avoid a second straight weekly decline. The benchmark index is down by almost 0.5% so far this week after…
